Found 104 results
Filters: Keyword is Biomarkers  [Clear All Filters]
2021
Merritt K, McGuire PK, Egerton A, Aleman A, Block W, Bloemen OJN, Borgan F, Bustillo JR, Capizzano AA, Coughlin JMarie et al..  2021.  Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.. JAMA Psychiatry. 78(6):667-681.
Schelbaum E, Loughlin L, Jett S, Zhang C, Jang G, Malviya N, Hristov H, Pahlajani S, Isaacson R, Dyke JP et al..  2021.  Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife.. Neurology. 97(23):e2328-e2339.
Sharma R, Reinstadler B, Engelstad K, Skinner OS, Stackowitz E, Haller RG, Clish CB, Pierce K, Walker MA, Fryer R et al..  2021.  Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.. J Clin Invest. 131(2)
Tahmi M, Rippon B, Palta P, Sherwood G, Hernandez G, Soto L, Ceballos F, Pardo M, Laing K, Igwe K et al..  2021.  In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics.. J Alzheimers Dis. 82(1):317-325.
Mosconi L, Berti V, Dyke J, Schelbaum E, Jett S, Loughlin L, Jang G, Rahman A, Hristov H, Pahlajani S et al..  2021.  Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.. Sci Rep. 11(1):10867.
Gillen KM, Mubarak M, Park C, Ponath G, Zhang S, Dimov A, Levine-Ritterman M, Toro S, Huang W, Amici S et al..  2021.  QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions.. Ann Clin Transl Neurol. 8(4):877-886.
Shah SA, Gautam R, Lowder R, Mauer EA, Carullo RB, Parlatore DE, Gerber LM, Schiff ND, Traube C.  2021.  Quantitative Electroencephalographic Markers of Delirium in the Pediatric Intensive Care Unit: Insights From a Heterogenous Convenience Sample.. J Neuropsychiatry Clin Neurosci. 33(3):219-224.
Palta P, Rippon B, Tahmi M, Pardo M, Johnson A, Tomljanovic Z, He H, Laing KK, Razlighi QR, Teresi JA et al..  2021.  Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults.. Neurobiol Aging. 103:109-116.
Dean KE, Shen B, Askin G, Schweitzer AD, Shahbazi M, Wang Y, Lange D, Tsiouris AJohn.  2021.  A specific biomarker for amyotrophic lateral sclerosis: Quantitative susceptibility mapping.. Clin Imaging. 75:125-130.
Hojjati SHani, Feiz F, Ozoria S, Razlighi QR.  2021.  Topographical Overlapping of the Amyloid-β and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity.. J Alzheimers Dis. 83(1):407-421.
2019
Goudey B, Fung BJ, Schieber C, Faux NG.  2019.  A blood-based signature of cerebrospinal fluid Aβ status.. Sci Rep. 9(1):4163.
Tsapanou A, Habeck C, Gazes Y, Razlighi Q, Sakhardande J, Stern Y, Salthouse TA.  2019.  Brain biomarkers and cognition across adulthood.. Hum Brain Mapp. 40(13):3832-3842.
Wen Y, Weinsaft JW, Nguyen TD, Liu Z, Horn EM, Singh H, Kochav J, Eskreis-Winkler S, Deh K, Kim J et al..  2019.  Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation - initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization.. J Cardiovasc Magn Reson. 21(1):70.
Guo Y, Chen Y, Zhang X, Mei Y, Yi P, Wang Y, Feng Q, La Tegola L, Guglielmi G, Zhang X et al..  2019.  Magnetic Susceptibility and Fat Content in the Lumbar Spine of Postmenopausal Women With Varying Bone Mineral Density.. J Magn Reson Imaging. 49(4):1020-1028.
Lee G, Nho K, Kang B, Sohn K-A, Kim D.  2019.  Predicting Alzheimer's disease progression using multi-modal deep learning approach.. Sci Rep. 9(1):1952.
Kam K, Parekh A, Sharma RA, Andrade A, Lewin M, Castillo B, Bubu OM, Chua NJ, Miller MD, Mullins AE et al..  2019.  Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau.. Mol Neurodegener. 14(1):10.
Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Benarous FGuillo, Ulysse A, Oo T, Vedvyas A et al..  2019.  Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).. J Alzheimers Dis. 67(2):685-705.